Perrigo Mucus-ER Drug Facts

Manufacturer
L. Perrigo Company
Effective date
2026-09-03
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
daily-update
Hydrated at
2026-09-08 02:02:38

Label at a glance#

Productgood sense mucus er
Active ingredientGUAIFENESIN
Label structure9 sections

Indications and uses

• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Dosage and administration

• do not crush, chew, or break extended-release tablet • take with a full glass of water • this product can be administered without regard for the timing of meals • adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours. • children under 12 years of age: do not use

Label contents#

Full prescribing information#

Active ingredient (in each extended-release tablet)

OTC - ACTIVE INGREDIENT SECTION

Guaifenesin 600 mg

Purpose

OTC - PURPOSE SECTION

Expectorant

Uses

INDICATIONS & USAGE SECTION

  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

  • for children under 12 years of age

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

    These could be signs of a serious illness.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not crush, chew, or break extended-release tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours.
  • children under 12 years of age: do not use

Other information

OTHER SAFETY INFORMATION

  • store at 20-25°C (68-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

carbomer homopolymer type B, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate,

microcrystalline cellulose, sodium starch glycolate

Questions or comments?

OTC - QUESTIONS SECTION

1-800-719-9260

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GOODSENSE®

12 Hour

Mucus•ER

Guaifenesin Extended-Release Tablets, 600 mg

Actual Size

Expectorant

• Relieves Chest Congestion

• Thins and Loosens Mucus

• Immediate and Extended Release

Compare to active ingredient of Mucinex®

20 Extended-Release Tablets

mucus-er
mucus-er

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0113-2023-58EA - Each0113-2023da17e939-5569-4a7c-85e5-13ec7435944512025-09-12
0113-2023-60EA - Each0113-2023db504b76-520e-44b1-8ece-c0a9aee4c2be12022-07-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0113-20230113-2023-60, 0113-2023-58

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
32025-02-20full-release2026-06-01 00:56:24

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078912-001GUAIFENESINGUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23
A078912-002GUAIFENESINGUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 81 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-2384e616aacf4f…
2026-09-14 22:38:342026-08A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-0584e616aacf4f…
2026-08-18 06:07:402026-07A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23caaa826d4ba7…
2026-08-18 06:07:402026-07A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-0531067a03dcf5…
2025-08-23 18:47 UTC2025-08A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-056a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-2303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-0503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-232680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-052680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-235bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-055bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23d06236e962d9…
2024-10-29 15:01 UTC2024-10A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-2379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-0579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-05301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-231e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-051e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-238072bd15b7f6…
2024-05-31 18:47 UTC2024-05A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-058072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-235c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-055c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-235d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-055d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-234b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A078912-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2020-11-054b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-2374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A078912-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2011-11-23bb7c543d1eb4…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
good sense mucus erGUAIFENESINL. Perrigo Companydef40c3f-29de-4efc-b1d3-4cb89183aaec2026-09-03WarningsExact identifier
ndc (package): 0113-2023-60
ndc (package): 0113-2023-58
ndc (product): 0113-2023
ndc11 (package): 00113202360
ndc11 (package): 00113202358
spl id: ce0344da-df70-4ceb-a64b-c71bb17d8b37
spl set id: def40c3f-29de-4efc-b1d3-4cb89183aaec

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.